Stay updated on Rational Epigenetic Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Rational Epigenetic Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rational Epigenetic Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The PRECISE trial record for second-line treatment of non-small cell lung cancer is now accessible, with details on the nivolumab and THU-decitabine study arms, participant criteria, and measured outcomes.
    Difference
    58%
    Check dated 2026-11-08T11:56:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T12:25:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH updates and explains that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in some content.
    Difference
    1%
    Check dated 2026-10-25T12:43:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision indicator changes from v3.7.1 to v3.7.2 while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-18T12:27:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:09:07.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details and documents with an error screen; the content appears inaccessible due to restricted access.
    Difference
    20%
    Check dated 2026-09-20T20:09:34.000Z thumbnail image

Stay in the know with updates to Rational Epigenetic Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rational Epigenetic Immunotherapy Clinical Trial page.